Profil
Anthony G.
Quinn worked as Head-Clinical Research & Exploratory Development at Roche Palo Alto LLC from 2005 to 2009.
Served as Chief Medical Officer & Executive Vice President at Synageva BioPharma Corp.
from 2014 to 2015.
Held the position of President, Chief Executive Officer & Director at Spyre Therapeutics, Inc. from 2018 to 2022.
Acted as Independent Director at Kaleido Biosciences, Inc. from 2016 to 2022 and at Generation Bio Co. from 2017 to 2026.
Worked as Director-Experimental Medicine at AstraZeneca PLC.
Held roles as Principal at Charnwood Group, and Professor at London School of Hygiene & Tropical Medicine and St Bartholomew's Hospital Medical College.
Education includes undergraduate and graduate degrees from the University of Dundee conferred in 1982 and 1985, respectively, and a doctorate from Newcastle University conferred in 1994.
Anciens postes connus de Anthony Quinn
| Sociétés | Poste | Fin |
|---|---|---|
| GENERATION BIO CO. | Directeur/Membre du Conseil | 06/02/2026 |
| SPYRE THERAPEUTICS, INC. | Directeur Général | 24/08/2022 |
| KALEIDO BIOSCIENCES, INC. | Directeur/Membre du Conseil | 01/06/2022 |
| SYNAGEVA BIOPHARMA CORP | Directeur Technique/Scientifique/R&D | 01/06/2015 |
Roche Palo Alto LLC
Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Discovers and develops medicines | Corporate Officer/Principal | 01/08/2009 |
Formation de Anthony Quinn
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Spyre Therapeutics, Inc.
Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Roche Palo Alto LLC
Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Discovers and develops medicines | Health Technology |
Charnwood Group
Charnwood Group Containers/PackagingProcess Industries Manufactures elastic products | Process Industries |
Newcastle University
Newcastle University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University Of Dundee
University Of Dundee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
London School of Hygiene & Tropical Medicine
London School of Hygiene & Tropical Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Synageva BioPharma Corp.
Synageva BioPharma Corp. BiotechnologyHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
St Bartholomew's Hospital Medical College
St Bartholomew's Hospital Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kaleido Biosciences, Inc.
Kaleido Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company which develops therapeutic products to systematically shape the micro biome | Health Technology |
Generation Bio Co.
Generation Bio Co. Pharmaceuticals: MajorHealth Technology Develops and commercializes genetic medicines | Health Technology |
















